Chongqing Zhifei Biological Products Co., Ltd. Overview
Pro stress-test →Chongqing Zhifei Biological Products engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. Founded in 2002, the company has become a major biopharmaceutical player specializing in human vaccines across multiple therapeutic areas.
Strategic Profile
Pro stress-test →Zhifei operates an extensive service network supplying vaccines to over 30,000 vaccination points across 31 provinces in China. The company has built a proprietary cold chain system with real-time temperature monitoring, enabling safe long-distance vaccine transportation. This infrastructure provides competitive advantages in vaccine distribution across China's diverse healthcare landscape.
Competitive Landscape
Pro stress-test →Zhifei competes in China's biopharmaceutical and vaccine sector against both state-owned and private enterprises. As the first privately-run vaccine enterprise listed on China's ChiNext, Zhifei maintains competitive advantages through its extensive distribution network, cold chain infrastructure, and diversified vaccine portfolio. Competition includes state-backed vaccine producers and other private biotech firms developing vaccines for infectious diseases.
Industry Context
Chongqing Zhifei Biological Products Co., Ltd. operates in Biopharmaceuticals - Vaccine Manufacturing & Distribution.
Key facts
Founded: 2002 · Headquarters: Chongqing, China · Employees: 7,220 · Revenue: $3.6B (2024) · Market cap: $6.1B